Patients Keeping stigma out of it: Personalising the mental health co... Thursday 10th October was World Mental Health Day, focused this year on ‘mental health at work’.
Views & Analysis A problem combination? Leela Barham takes stock of past NICE decisions for combinations to explore the scale of the reimbursement challenge for combination therapies.
Partner Content Partner Content When science and biology combine – the outlook for ADCs in c... Antibody Drug Conjugates (ADCs) are treatments formed by the conjugation of monoclonal antibodies and cytotoxic agents.
News JPM: AbbVie pays $650m upfront for RemeGen cancer drug AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
